Ikarian Capital, LLC Arrowhead Pharmaceuticals, Inc. Put Options Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $12.3 Million - $18.1 Million	-200,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $8.76 Million - $17.1 Million	200,000 New	200,000 $15.3 Million
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $188,064 - $311,544	-7,200 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $1.91 Million - $5.86 Million	-92,800 Reduced 92.8%	7,200 $207,000
Q4 2019 Jan 31, 2020	BUY	$28.14 - $73.01 $2.81 Million - $7.3 Million	100,000 New	100,000 $6.34 Million

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.